Consideration of ledipasvir/sofosbuvir as an alternative to glecaprevir/pibrentasvir based upon on-treatment FIB-4 changes and sustained virologic response at 12 weeks in hepatitis C genotype 1 and 2 infections: A propensity score-matched study. [PDF]
Medicine (Baltimore)Park HJ +5 more
europepmc +1 more source
Additive Effects of Amines on Asymmetric Hydrogenation of 2-Substituted Quinoxalines Catalyzed by Chiral Iridium Dinuclear Complexes and Mechanistic Study [PDF]
ナガノ, タクト, 長野, 卓人
core
Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study. [PDF]
Medicina (Kaunas)Kim JH +8 more
europepmc +1 more source
Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks. [PDF]
J VirolFedorchenko SV +4 more
europepmc +1 more source
Recent Advances in the Synthesis of Organic Thiocyano (SCN) and Selenocyano (SeCN) Compounds, Their Chemical Transformations and Bioactivity. [PDF]
MoleculesAbonia R +3 more
europepmc +1 more source
Recent advances on anticancer activity of benzodiazine heterocycles through kinase inhibition. [PDF]
RSC AdvNafie MS +5 more
europepmc +1 more source
Related searches:
AbstractFor Abstract see ChemInform Abstract in Full Text.
S. Gobec, U. Urleb
openaire +1 more source